Table 3.
Scale | 95% CIs for model estimates (by milestone) | ||||
---|---|---|---|---|---|
Intake | Change versus intake | ||||
M 1 | M 2 | M 3 | M 4 | M 5 | |
PSS-10 | [22.2, 26.8] | [−11.2, −6.2] | [−10.3, −4.9] | [−12.2, −6.0] | [−14.5, −7.1] |
GSI | [1.2, 1.7] | [−0.8, −0.2] | [−0.8, −0.2] | [−1.1, −0.4] | [−1.3, −0.5] |
CEQ-F | [53.0, 67.5] | [−43.0, −28.1] | [−41.5, −25.8] | [−53.4, −34.9] | [−59.8, −37.7] |
CEQ-F, Craving Experience Questionnaire (frequency); CI, confidence interval; GSI, Global Severity Index; Mn, treatment milestone; PSS-10, Perceived Stress Scale (10-item version).
Significance values. p < 0.001 for all estimates except for GSI M3 (p < 0.01).